Clinical Trial Update: The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin in patients with metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: UNKNOWN